Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
J Family Med Prim Care ; 13(3): 990-996, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38736772

ABSTRACT

Background: Mobile health applications are an established tool for healthcare management, patient education, and even capacity building for healthcare providers. However, its use among traditional birth attendants (TBAs) is limited. The aim of this study is to explore the needs and bottlenecks of developing an interactive mobile application for maternal and infant care (MAI) of TBAs. Materials and Methods: It is a qualitative study having in-depth interviews (face-to-face approach) conducted among the seekers of MAI services. Setting: This study is conducted in tribal and rural locations in the district Sirohi, Rajasthan. Participants: TBAs and tribal females of reproductive age in tribal-dominated areas have participated. The development of an interactive mobile application MAI has three phases: (1) a need-based approach to identify the needs on the ground; (2) identifying intervention bottlenecks and possible solutions; (3) design and development of the mobile application. Results: Ninety-six tribal females of reproductive age participated in the needs assessment. Eighty percent of them were ≤ 30 years of age and 40% of them were uneducated. Most participants informed that lack of information (culturally/locally appropriate content), peer advocacy, affordability, lack of transportation, and the influence of TBAs are the significant factors for less uptake of maternity and child health services in the tribal and rural areas. Conclusion: The MAI app has culturally/locally appropriate content and is prepared by the local TBAs and Accredited Social Health Activists, with full local character and clothing. MAI app has videos and audio in the local language (Marwari) with pictorial quizzes. Using the MAI app, TBAs may self-educate and guide tribal pregnant women about maternal hygiene and infant healthcare as needed at various stages of pregnancy and childbirth.

2.
Int J Med Inform ; 182: 105305, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38061185

ABSTRACT

PURPOSE: Cancer patients struggle with the trauma of the disease and its treatment. PRO-CTCAE was developed to improve the recording of underreported symptomatic toxicities. We evaluated the improvement and ease in reporting symptomatic adverse events through add-on PRO-CTCAE (via a mobile application) compared to standard clinician-reported outcomes in routine clinical practice. We also evaluated changes in the health-related quality of life (HRQoL). METHODS: 110 cancer patients were studied for three weeks between their first and second chemotherapy session. HRQoL was assessed using EORTC QLQ-c30. RESULTS: Fifty-three patients self-reported their symptomatic adverse events on the day 7th & day 14th after the first cycle of chemotherapy. For the other fifty-seven patients, recording of adverse events was done by standard clinician-reported outcomes. All the patients in the study group reported adverse events compared to only 21 % in the standard reporting group. All 15 domains of adverse events were reported in the self-reporting group compared to only 5 in the standard reporting group. The self-reporting group had a significantly better overall quality of life. CONCLUSIONS: Self-reporting of adverse events using mobile app-based PRO-CTCAE helps patients and clinicians with better documentation of symptomatic toxicities of chemotherapy, reducing the burden on physicians and improving patient satisfaction. Mobile app-based self-reporting empowers cancer patients undergoing treatment, improves their quality of life, and should be implemented in routine clinical practice. Wider implementation can lead to further optimised solutions.


Subject(s)
Neoplasms , Quality of Life , Humans , Patient Reported Outcome Measures , Neoplasms/drug therapy , Medical Oncology , Self Report
3.
Comput Biol Med ; 146: 105587, 2022 07.
Article in English | MEDLINE | ID: mdl-35551007

ABSTRACT

Recent years have seen deep neural networks (DNN) gain widespread acceptance for a range of computer vision tasks that include medical imaging. Motivated by their performance, multiple studies have focused on designing deep convolutional neural network architectures tailored to detect COVID-19 cases from chest computerized tomography (CT) images. However, a fundamental challenge of DNN models is their inability to explain the reasoning for a diagnosis. Explainability is essential for medical diagnosis, where understanding the reason for a decision is as important as the decision itself. A variety of algorithms have been proposed that generate explanations and strive to enhance users' trust in DNN models. Yet, the influence of the generated machine learning explanations on clinicians' trust for complex decision tasks in healthcare has not been understood. This study evaluates the quality of explanations generated for a deep learning model that detects COVID-19 based on CT images and examines the influence of the quality of these explanations on clinicians' trust. First, we collect radiologist-annotated explanations of the CT images for the diagnosis of COVID-19 to create the ground truth. We then compare ground truth explanations with machine learning explanations. Our evaluation shows that the explanations produced. by different algorithms were often correct (high precision) when compared to the radiologist annotated ground truth but a significant number of explanations were missed (significantly lower recall). We further conduct a controlled experiment to study the influence of machine learning explanations on clinicians' trust for the diagnosis of COVID-19. Our findings show that while the clinicians' trust in automated diagnosis increases with the explanations, their reliance on the diagnosis reduces as clinicians are less likely to rely on algorithms that are not close to human judgement. Clinicians want higher recall of the explanations for a better understanding of an automated diagnosis system.


Subject(s)
COVID-19 , Algorithms , COVID-19/diagnostic imaging , Humans , Machine Learning , Neural Networks, Computer , Trust
4.
Biomed Res Int ; 2021: 5560144, 2021.
Article in English | MEDLINE | ID: mdl-34124246

ABSTRACT

PURPOSE: This study was aimed at comparing the effects of TheraBand and theratube eccentric exercises on quadriceps muscle strength in young adults. METHODS: Thirty young adults (19 females, 11 males) participated in this pretest-posttest experimental study. Participants were randomly assigned to one of the two groups: TheraBand and theratube groups. They received the training intervention 3 times a week for 4 weeks (12 sessions) with progression after 2 weeks. Maximum eccentric quadriceps strength was assessed using the Biodex isokinetic dynamometer system. Additionally, quadriceps muscle mass was measured using a tape. RESULTS: Both groups showed a significant improvement in the peak torque of the eccentric isokinetic quadriceps' strength after weeks 2 and 4. Strength change in the quadriceps was nonsignificant in the theratube group compared to the TheraBand group after 4 weeks of training (p < 0.05). There was no increase in muscle mass during the 4 weeks of training in any group (p > 0.05). CONCLUSION: Both the TheraBand and theratube are equally effective in the strengthening of the quadriceps muscle in young adults. Therefore, either the TheraBand or theratube may be used according to the availability and feasibility of the subjects for training intervention.


Subject(s)
Exercise/physiology , Muscle Strength/physiology , Quadriceps Muscle/physiology , Adolescent , Adult , Female , Humans , Male , Young Adult
5.
J Family Med Prim Care ; 9(11): 5435-5436, 2020 Nov.
Article in English | MEDLINE | ID: mdl-33532374

ABSTRACT

In the present scenario of COVID-19, there has been a sudden surge in demand for tele- consultancy. Such measures require resources to support the system. Replacement of conventional equipment used in a clinic with digital equipment is not feasible due to their cost and scalability issues. The authors developed a simple low-cost (almost zero cost) method to convert a conventional stethoscope into a tele-stethoscope. Such a simple modification can be useful in periphery wherein doctors are still not available and the growing number of patients would require a diagnosis of the chest conditions.

6.
Anesth Essays Res ; 13(1): 126-131, 2019.
Article in English | MEDLINE | ID: mdl-31031492

ABSTRACT

INTRODUCTION: Ventral hernia is a commonly performed surgical procedure in adults. Laparoscopic intraperitoneal onlay mesh repair (IPOM) of ventral hernia is procedure of choice. IPOM of ventral hernia is associated with significant pain. Hence, our aim was to study the efficacy of instilling preemptive local analgesia for reducing postoperative pain in patients undergoing laparoscopic ventral hernia repairs. OBJECTIVE: To study the role of local infiltration of 10 ml of 0.5% ropivacaine in the anterior abdominal wall preoperatively to improve pain scores compared to conventional intravenous systemic analgesia. MATERIALS AND METHODS: The study pool consists of two groups of patients (25 in each group) admitted for laparoscopic uncomplicated ventral hernia repair. Analysis was performed by the SPSS program (Company - International Business Machines Corporation, headquartered at Armonk, New York, USA) for Windows, version 17.0. Normally distributed continuous variables were compared using ANOVA. Categorical variables were analyzed using the Chi-square test. RESULTS: Both groups were matching in terms of demographic features. Postoperatively, pain assessment was performed every 30 min for the first 2 h and was followed up for a period of 24 h at intervals (4, 6, 12, and 24 h). Postoperatively, patients were also assessed for time of ambulation, time of return of bowel sounds at 6, 12, and 24 h, and length of hospital stay. Side effects and complication were noted. CONCLUSION: Our study demonstrated that supplementing US-guided transversus abdominis plane (TAP) block to conventional systemic analgesics resulted in decreased VAS scores and decreased requirement of rescue analgesics. The patients ambulated early had earlier appearance of bowel sounds and decreased length of hospital stay. There was also decreased incidence of nausea and vomiting. TAP block for laparoscopic IPOM surgery significantly decreases postoperative pain and opioid requirement in patients.

7.
Anticancer Res ; 35(4): 1851-9, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25862838

ABSTRACT

The mevalonate pathway plays an important role in cancer biology and has been targeted with farnesyl transferase inhibitors, although their efficacy is limited due to significant adverse effects. Statins and bisphosphonates inhibit the mevalonate pathway at different steps, thus having negative effects at various levels on cancer cells. A combination of these drugs may result in an amplified cytotoxic effect and allow for use of significantly lower doses of the drugs involved. Statins inhibit the mevalonate pathway at 3-hydroxy-3-methylglutaryl coenzyme A reductase and bisphosphonates at farnesyl pyrophosphate synthase. Our results show that low-dose combinations of simvastatin and alendronate have a synergistic cytotoxic effect on androgen-independent prostate cancer PC-3 cells, but not on androgen-dependent LNCaP or DU 145 prostate cancer cells. These two drugs cause a sequential blockade of the mevalonate pathway and significantly affect survival and apoptotic pathways by down-regulating phospho-AKT and activating c-JUN and ERK.


Subject(s)
Alendronate/administration & dosage , Drug Synergism , Prostatic Neoplasms/drug therapy , Simvastatin/administration & dosage , Apoptosis/drug effects , Cell Line, Tumor , Dose-Response Relationship, Drug , Gene Expression Regulation, Neoplastic/drug effects , Humans , JNK Mitogen-Activated Protein Kinases/biosynthesis , Male , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Proto-Oncogene Proteins c-akt/biosynthesis
8.
Saudi J Anaesth ; 4(3): 178-81, 2010 Sep.
Article in English | MEDLINE | ID: mdl-21189856

ABSTRACT

OBJECTIVES: A study to compare the efficacy between fentanyl and sufentanil combined with low concentration (0.0625%) of bupivacaine for epidural labor analgesia in laboring women MATERIALS AND METHODS: Fifty full term parturients received an initial bolus dose of a 10 ml solution containing 0.125% bupivacaine. The patients were randomly divided into two: group F received 0.0625% bupivacaine with 2.5 mcg/ml fentanyl and group S received 0.0625% bupivacaine with 0.25 mcg/ml sufentanil. Verbal analogue pain scores, need of supplementary/rescue boluses dose of bupivacaine consumed, mode of delivery, maternal satisfaction, and neonatal Apgar scores were recorded. No significant difference was observed between both groups. RESULTS: Both the groups provided equivalent labor analgesia and maternal satisfaction. The chances of cesarean delivery were also not increased in any group. No difference in the cephalad extent of sensory analgesia, motor block or neonatal Apgar score were observed. Although mean pain scores throughout the labor and delivery were similar in both groups, more patients in fentanyl group required supplementary boluses though not statistically significant. CONCLUSION: We conclude that both 0.0625% bupivacaine-fentanyl (2.5 µg/ml) and 0.0625% bupivacaine-sufentanil (0.25 µg/ml) were equally effective by continuous epidural infusion in providing labor analgesia with hemodynamic stability achieving equivalent maternal satisfaction without serious maternal or fetal side effects. We found that sufentanil was 10 times more potent than fentanyl as an analgesic for continuous epidural labor analgesia.

9.
South Med J ; 103(3): 245-7, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20134390

ABSTRACT

We report a rare case of Candida glabrata liver abscess and fungemia complicating severe calculus cholecystitis in a 64-year-old female patient who had no history of immunosuppression or diabetes mellitus. The patient underwent cholecystectomy, resection of liver abscess, and systemic antifungal therapy using micafungin.


Subject(s)
Candida glabrata/isolation & purification , Candidiasis/complications , Cholecystitis/microbiology , Fungemia/complications , Antifungal Agents/administration & dosage , Candidiasis/drug therapy , Cholangiopancreatography, Endoscopic Retrograde , Cholecystectomy , Cholecystitis/diagnostic imaging , Cholecystitis/surgery , Drug Administration Schedule , Drug Resistance, Fungal , Echinocandins/administration & dosage , Female , Fungemia/drug therapy , Humans , Immunocompetence , Middle Aged , Tomography, X-Ray Computed
11.
JOP ; 10(4): 421-4, 2009 Jul 06.
Article in English | MEDLINE | ID: mdl-19581748

ABSTRACT

CONTEXT: Pseudocysts are a common complication of acute and chronic pancreatitis. These are usually located within the pancreas but they can occur at other sites as well, including the mediastinum, neck, pelvis and rarely in the liver as in our case. The diagnosis of intrahepatic pancreatic pseudocyst relies on the demonstration of a high amylase level in the sampled cystic fluid in the absence of infection or neoplasm. CASE REPORT: A 60-year-old man with a history of chronic pancreatitis presents with a clinical and laboratory picture suggestive of acute exacerbation of his pancreatitis. A computed tomogram (CT) scan of the abdomen revealed a pancreatic pseudocyst and a cystic lesion involving both lobes of the liver. CT diagnostic aspiration of the intrahepatic cyst revealed high amylase level (greater than 20,000 U/L). The cyst was treated with percutaneous drainage with complete resolution of the cyst. CONCLUSION: In the setting of pancreatitis, intrahepatic pancreatic pseudocyst should be considered in the differential diagnosis of cystic lesion of the liver.


Subject(s)
Cysts/complications , Liver Diseases/complications , Pancreatic Pseudocyst/complications , Cysts/diagnosis , Cysts/therapy , Diagnosis, Differential , Drainage/methods , Humans , Liver Diseases/diagnosis , Liver Diseases/therapy , Male , Middle Aged , Pancreatic Pseudocyst/diagnosis , Pancreatic Pseudocyst/therapy , Pancreatitis, Chronic/complications , Treatment Outcome
12.
Postgrad Med ; 120(1): 18-27, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18467805

ABSTRACT

Acute coronary syndrome (ACS) refers to a group of clinical conditions caused by myocardial ischemia including unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI). Appropriate and accurate diagnosis has life-saving implications and requires a quick but thorough evaluation of the patient's history, physical examination, electrocardiogram, radiographic studies, and cardiac biomarkers. The management of patients with suspected or confirmed ACS continues to evolve as new evidence from clinical trials is considered and as new technology becomes available to both primary care physicians and cardiologists. Low- and intermediate-risk patients have frequently been managed in a chest pain center or in the emergency department. While stress testing with or without radionuclide imaging is the most common evaluation method, a CT angiogram is sometimes substituted. High-risk patients are often managed with an early invasive strategy involving left heart catheterization with a goal of prompt revascularization of at-risk, viable myocardium. With the increased availability of cardiac catheterization facilities, patients with STEMI are more commonly being managed with primary percutaneous coronary intervention, although thrombolysis is still used where such facilities are not immediately available. This article provides primary care physicians with a concise review of the pathophysiology, clinical evaluation, and management of ACS based on the best available evidence in 2008.


Subject(s)
Acute Coronary Syndrome/diagnosis , Acute Coronary Syndrome/therapy , Guidelines as Topic , Humans , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...